Regulatory Scope Creep

“New regulations changed the rules after you built your company around the old ones.”

Structural failure pattern in healthcare B2B

28 companies failed due to regulatory scope creep in the Stressline corpus.

Deaths

Funding Raised by Companies That Failed

$2.6B

Sub-Vertical Breakdown

Compliance & Regulatory11 (39%)

Clinical Workflow & Documentation4 (14%)

Other Healthcare B2B4 (14%)

Revenue Cycle Management2 (7%)

Behavioral Health & Mental Health2 (7%)

Credentialing & Provider Enrollment1 (4%)

Care Coordination & Transitions1 (4%)

Digital Therapeutics & DTx1 (4%)

Pharmacy Technology & Delivery1 (4%)

Health Insurance & Benefits1 (4%)

Founding Year Timeline

2005

2010

2012

2013

2014

2015

2016

2017

2020

2022

2024

28 companies, 73 failure dimensions coded, 2005–2024.

Related failure patterns

Outspent by bigger competitors Product claims exceeded actual capabilities Couldn't get paid by insurance

28 companies hit regulatory scope creep. Will yours?

Stress-test your thesis →

Get Alerts for This Pattern

New data gets coded regularly. Get notified when this failure pattern updates.

Related methodology

All failure patterns →How the corpus is built →How scoring works →

Data sourced from SBIR/STTR databases, SEC EDGAR filings, ClinicalTrials.gov, CMS data, and founder postmortems. Coded using the Gioia qualitative methodology. Read the methodology.